Literature DB >> 1812499

Coincidence of schizophrenia and hyperbilirubinemia.

N Müller1, P Schiller, M Ackenheil.   

Abstract

In a retrospective study, the bilirubin plasma concentrations of every patient admitted to the Psychiatric Hospital were collected. Patients suffering from liver disease, substance abuse, overt hemolysis, or increased liver enzymes were excluded. Schizophrenics showed a significantly higher incidence of hyperbilirubinemia than patients suffering from other psychiatric disorders. This phenomenon seems to be independent of drug usage and therefore points to a relationship between hyperbilirubinemia and schizophrenic psychosis. Hypothetic explanations, such as a possible genetic disposition for Gilbert Syndrome, an increased vulnerability of red-cell membranes, and the role of estrogens in schizophrenic patients, are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1812499     DOI: 10.1055/s-2007-1014472

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  7 in total

1.  Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).

Authors:  Rei Yasukawa; Tsuyoshi Miyaoka; Shoichi Mizuno; Takuji Inagaki; Jun Horiguchi; Kazushige Oda; Hajime Kitagaki
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

Review 2.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

3.  Oxidative Stress-Induced Response of Some Endogenous Antioxidants in Schizophrenia.

Authors:  Gora Dadheech; Praveen Sharma; Shiv Gautam
Journal:  Indian J Clin Biochem       Date:  2012-03-23

4.  Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model.

Authors:  Kristian Liaury; Tsuyoshi Miyaoka; Toshiko Tsumori; Motohide Furuya; Rei Wake; Masa Ieda; Keiko Tsuchie; Michiyo Taki; Kotomi Ishihara; Andi Jayalangkara Tanra; Jun Horiguchi
Journal:  J Neuroinflammation       Date:  2012-03-16       Impact factor: 8.322

5.  Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.

Authors:  Shoko Miura; Keiko Tsuchie; Michiyo Fukushima; Ryosuke Arauchi; Toshiko Tsumori; Koji Otsuki; Maiko Hayashida; Sadayuki Hashioka; Rei Wake; Tsuyoshi Miyaoka; Masatoshi Inagaki; Arata Oh-Nishi
Journal:  Pediatr Res       Date:  2021-03-31       Impact factor: 3.756

6.  Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects.

Authors:  Alberto Bocchetta
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-06-13

7.  Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study.

Authors:  Zhe Lu; Tianyang Wen; Yingtan Wang; Weijing Kan; Guanglei Xun
Journal:  BMC Psychiatry       Date:  2020-05-15       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.